Physician

Kalpesh Himat Solanki, DO

According to 2025 Medicare claims, Kalpesh Solanki, DO (NPI: 1245325570) practices cardiology in the Ocala, FL market, with the plurality of this provider's patient population coming from Marion, FL. This provider's primary affiliated billing organization is CARDIOVASCULAR INSTITUTE OF CENTRAL FLORIDA, LLC (NPI: 1679666598; TIN: 20-5476847) and primary practice location at 34476-5575.

Solanki's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,352 traditional Medicare patients, billed 9,049 HCPCS/CPT codes, and received $1,217,327 in Medicare payments. The top billing code was 93306 (Ultrasound of heart with color-depicted blood flow, rate, direction and valve function). Part D data shows 5,951 prescription claims across 1,053 beneficiaries totaling $1,342,259 in drug costs, led by Eliquis (Apixaban). 2020 DME data shows 16 claims. Open Payments data shows 130 records totaling $6,022. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $833,499 to $1,217,327. Similarly, Part D prescription costs have moved sharply higher in recent years, from $113,633 to $1,342,259. In contrast, DME billing represents a smaller volume and fell sharply in recent years, from $24,737 to $22,692.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	858	10,085	$833,499
2016	826	10,851	$587,845
2017	1,035	16,135	$829,807
2018	1,292	10,526	$1,136,208
2019	1,549	10,025	$1,108,961
2020	1,420	12,177	$1,219,164
2021	1,483	11,591	$1,251,119
2022	1,461	9,605	$1,156,355
2023	1,427	10,079	$1,099,999
2024	1,352	9,049	$1,217,327

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	257	1,801	$113,633
2016	283	1,645	$189,366
2017	353	2,069	$246,739
2018	420	2,286	$286,309
2019	521	2,593	$387,604
2020	609	3,228	$568,033
2021	743	4,019	$815,976
2022	827	4,501	$956,748
2023	952	5,206	$1,171,004
2024	1,053	5,951	$1,342,259

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	11	$24,106
2016	N/R	26	$31,833
2017	N/R	29	$35,660
2018	N/R	20	$40,553
2019	N/R	N/R	N/R
2020	N/R	16	$29,520
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	500	505	$117
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	551	766	$98
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	595	857	$68
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	331	378	$14
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	538	567	$10

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	468	31,503	$595,040
Xarelto	Rivaroxaban	189	13,434	$244,265
Entresto	Sacubitril/Valsartan	154	9,381	$200,632
Repatha Sureclick	Evolocumab	85	4,910	$94,638
Multaq	Dronedarone Hcl	21	1,470	$37,641

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	130	$6,022	Abbott Laboratories
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Kalpesh Himat Solanki, DO?

Tedicare shows public-source Medicare data for Kalpesh Himat Solanki, DO (NPI 1245325570), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Kalpesh Himat Solanki, DO have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Kalpesh Himat Solanki, DO?

Kalpesh Himat Solanki, DO is linked to CARDIOVASCULAR INSTITUTE OF CENTRAL FLORIDA, LLC (billing NPI 1679666598) in the available physician profile data.

Does Kalpesh Himat Solanki, DO have Open Payments data?

Kalpesh Himat Solanki, DO has 130 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.